AVITA's Q4 sales missed guidance due to hospitals deferring year end purchases. However, January's rebound suggests a strong ...

To register for the presentation, please follow this Zoom link: https://us02web.zoom.us/webinar/register/WN_Nx3kCIIOSmOj686nctwpRA. A replay will be available on the AVITA Medical website, ...

We expect Avita’s RECELL to pose a significant challenge to the standard of care for larger burns, currently a skin graft sourced from elsewhere on the patient’s body. We believe Avita will be ...

AVITA Medical (NASDAQ:RCEL – Get Free Report) will likely be posting its quarterly earnings results after the market closes ...

Cohealyx adds $1.35 billion in TAM, PermeaDerm contributes $135 million in TAM and RECELL provides a potential of $1.5 billion in TAM. In the aggregate, AVITA Medical now has a combined $3.5 ...

We came across a bullish thesis on AVITA Medical, Inc. (RCEL) on Substack by Steve Wagner. In this article, we will summarize ...

Discover how AVITA Medical’s new product launches, including Cohealyx and RECELL GO Mini, aim to boost revenue by up to 65% in 2025.

A replay will be available on the AVITA Medical website, ir.avitamedical.com, following the presentation. In international markets, the RECELL System is approved to promote skin healing in a wide ...

Tech: Avita's Recell. Valencia-based Avita Medical Inc. has received FDA approval for a version of its second-generation Recell skin cell harvesting device designed to treat small-scale wounds.

Valencia-based Avita Medical Inc. has received FDA approval for a version of its second-generation Recell skin cell harvesting device designed to treat small-scale wounds. Avita’s original device, ...